24th EHA Annual Meeting Published June 14, 2019 IMG 5715 « ‹ of 4 › » Recent news» Melflufen receives positive opinion from the European Medicines Agency (EMA) for the treatment of refractory myeloma» EHA 2022 highlights in myeloma and AL amyloidosis
